Brief Title: Aerobic Training on Cerebrovascular Function, Cognition and Gait in Parkinson's Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorRaphael Mendes Ritti Dias

About this trial

This randomized controlled trial will investigate the effects of a 12-week supervised aerobic training program on cerebrovascular function, peripheral vascular health, cardiovascular autonomic modulation, cognition, non-motor symptoms, sleep, mood, gait biomechanics, quality of life, and body composition in patients with Parkinson's disease (Hoehn \& Yahr stages 1-3). Participants will be randomly allocated to aerobic training or usual care.

Eligibility criteria

Qualifiers

Clinical diagnosis of Parkinson's disease

Hoehn & Yahr stages 1-3

Stable antiparkinsonian medication for at least 4 weeks

Montreal Cognitive Assessment (MoCA) score ≥ 18

Disqualifiers

Change in medication

Contraindication to exercise

Trial design

Treatments tested in this trial

  • Aerobic training
  • Usual Care

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Raphael Mendes Ritti Dias

Lead sponsor

University of Nove de Julho

Sponsor institution